The health-focused beverage chain is capitalizing on the rise of GLP-1 medications and a shift toward nutrient-dense diets. With a commitment to open hundreds of new stores, the company is pivoting its brand image and menu to meet evolving consumer demands.
- System-wide sales increased 64% over the past five years
- 2025 revenue rose 4% to $66.16 million, though net income fell 6% to $14.84 million
- Growth driven by GLP-1 drug adoption and a shift away from ultra-processed foods
- Plans to open 90 new stores this year and 200+ in the coming years
- New store designs and menu expansion into flatbreads underway
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.